These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30621453)

  • 1. Tiny and Forgotten: A Call for Focused Neonatal Policy Reform.
    Bucci-Rechtweg CM; Ward RM
    Ther Innov Regul Sci; 2019 Sep; 53(5):615-617. PubMed ID: 30621453
    [No Abstract]   [Full Text] [Related]  

  • 2. Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation.
    Bourgeois FT; Kesselheim AS
    N Engl J Med; 2019 Aug; 381(9):875-881. PubMed ID: 31461599
    [No Abstract]   [Full Text] [Related]  

  • 3. Adolescents and Drug Development: Commentary on a Dawning Paradigm Shift.
    Kearns GL; van den Anker JN
    J Clin Pharmacol; 2021 Jun; 61(6):740-743. PubMed ID: 33797778
    [No Abstract]   [Full Text] [Related]  

  • 4. Importing oncology trials from China: a bridge over troubled waters?
    Singh H; Pazdur R
    Lancet Oncol; 2022 Mar; 23(3):323-325. PubMed ID: 35131039
    [No Abstract]   [Full Text] [Related]  

  • 5. Minors and a Dawning Paradigm Shift in "Pediatric" Drug Development.
    Rose K; Tanjinatus O; Grant-Kels JM; Ettienne EB; Striano P; Neubauer D
    J Clin Pharmacol; 2021 Jun; 61(6):736-739. PubMed ID: 33368372
    [No Abstract]   [Full Text] [Related]  

  • 6. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.
    Sable CA; Ivy DD; Beekman RH; Clayton-Jeter HD; Jenkins KJ; Mahle WT; Morrow WR; Murphy MD; Nelson RM; Rosenthal GL; Stockbridge N; Wessel DL
    Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28663437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology.
    Rowe-Rendleman CL
    Pharm Res; 2019 Feb; 36(4):54. PubMed ID: 30790065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reforming the Orphan Drug Act for the 21st Century.
    Sarpatwari A; Kesselheim AS
    N Engl J Med; 2019 Jul; 381(2):106-108. PubMed ID: 31291512
    [No Abstract]   [Full Text] [Related]  

  • 9. Call for clinical-trial reform leaves critics unmoved.
    Powell K
    Nature; 2002 Oct; 419(6907):546. PubMed ID: 12374938
    [No Abstract]   [Full Text] [Related]  

  • 10. Model-Informed Assessment of Anti-Infectives for Young Children in Low- and Middle-Income Countries.
    Zhao P; Arm J; Ma LF; Ward S; Hermann D; Wesche D; Hartman D; Kern S
    CPT Pharmacometrics Syst Pharmacol; 2019 Apr; 8(4):201-204. PubMed ID: 30714344
    [No Abstract]   [Full Text] [Related]  

  • 11. Current Understanding of Medication Use in Pregnancy/Lactation and Neonates: What Are the Key Knowledge Gaps?
    Davis JM; Norwitz ER
    Clin Perinatol; 2019 Jun; 46(2):xvii-xviii. PubMed ID: 31010569
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer clinical trials: what is the impact of regulatory changes?
    Kearsey L
    ONS News; 2002 Sep; 17(9):1, 4-5. PubMed ID: 12244866
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent US Food and Drug Administration Efforts to Integrate the Patient's Perspective in Drug Development and Decision Making.
    Mullin T; Vaidya P; Chalasani M
    Clin Pharmacol Ther; 2019 Apr; 105(4):789-791. PubMed ID: 30609017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Dötsch J; Endres S
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S2. PubMed ID: 30453359
    [No Abstract]   [Full Text] [Related]  

  • 15. New Drugs and Clinical Trials Rules-2019: What academicians need to know.
    Lahiry S; Thakur S; Chakraborty DS
    Indian J Dermatol Venereol Leprol; 2020; 86(4):445-448. PubMed ID: 32394898
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA reform legislation and its effect on clinical trials.
    Phillips SJ
    ASAIO J; 2000; 46(1):19-20. PubMed ID: 10667708
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving protection for research subjects.
    Steinbrook R
    N Engl J Med; 2002 May; 346(18):1425-30. PubMed ID: 11986426
    [No Abstract]   [Full Text] [Related]  

  • 18. A delicate balancing act.
    Nat Rev Drug Discov; 2007 Sep; 6(9):685. PubMed ID: 17907339
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Perspective--Early Feasibility Device Medical Studies in the United States: Time for More Than Regulatory Reform.
    Holmes DR; Shuren J; Califf R; Zuckerman B; Abel D; Farb A; Leon M; Mack M
    JACC Cardiovasc Interv; 2016 Mar; 9(6):626-8. PubMed ID: 27013168
    [No Abstract]   [Full Text] [Related]  

  • 20. Speed and oversight: FDA Commissioner Gottlieb acts on pledges.
    Morrison C
    Nat Biotechnol; 2017 Oct; 35(10):898-899. PubMed ID: 29019996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.